c-MYC, a transcription factor aberrantly expressed in over 70% of human cancers [13], was engineered into a doxycycline-inducible cassette in these cells, leading to increased c-MYC expression upon doxycycline treatment [14]. The gene discussed is MYC; the disease is cancer.